Loading
No insider purchase over the last 90 days. The latest was filed 07 May 2026.
CXO: what insiders have been doing
CXO belongs to the Chemicals sector. Filings by its managers are published through ASX. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 4 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €338k, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 2 senior executives. The largest single trade was a purchase of €307k by Paul BROWN, published on 7 May 2026, equal to 0.044% of the market capitalisation.
Across the 2,527 companies tracked on its exchange, the median is 3 filings; at 5 filings, this issuer sits above that mark. Our records for CXO go back to 2026, with 2 purchases and no sales on the open market in total.
In the case of 1 purchase, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 7 May 2026, 163 days ago.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€337,953
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAlicia SHERWOOD1 buy
Paul BROWN1 buy
Since the insiders bought
- -40.6%Entry A$0.34 · Close 15 Oct 2026 A$0.20
- -40.6%Entry A$0.34 · Close 15 Oct 2026 A$0.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate CXO Buy (bullish), based on 3 analysts. Average price target: A$0.30.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.32
Analyst consensus
3 analystsBuy
A$0.25Target A$0.30(-7%)A$0.35
Income statement
Revenue-A$2.4M
Gross profit-A$5M206% margin
EBITDA-A$21.8M902% margin
Net income-A$23.4M-145.5% margin
Valuation
PER (forward)16.1x
P/Book2.8x
Beta0.81
Balance sheet & cash
Market capA$1B
Total debtA$2.9M
Free Cash Flow-A$63.3M
Debt / Equity9%
Profitability & ownership
ROE-8.5%
ROA-6.3%
% insiders5.2%
% institutions33.8%
Last declaration on 2 October 2026
Declarations5 total
ShareASXASX:2924-03143848-6A1347450
ShareASXASX:2924-03117176-6A1336984
ShareASXASX:2924-03113838-6A1335242
2,380,952 shares@ A$0.210.044% mcap100.0% of flowShareASXASX:2924-03088159-6A1324684
Canonical exit: 6 Aug 2026 (T+90)
238,095 shares@ A$0.210.0044% mcap100.0% of flowShareASXASX:2924-03088157-6A1324681
Canonical exit: 6 Aug 2026 (T+90)
5 of 5 declarations
About CXO
CXO is a company operating in the chemicals and materials sector, listed on the XASX. It focuses on the development and production of innovative solutions for various markets.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
